Axsome Therapeutics Inc (NAS:AXSM)
$ 93.35 0 (0%) Market Cap: 4.48 Bil Enterprise Value: 4.36 Bil PE Ratio: 0 PB Ratio: 43.42 GF Score: 39/100

Axsome Therapeutics Inc at Bank of America Global Healthcare Conference Transcript

May 11, 2023 / 04:20PM GMT
Release Date Price: $77.97 (-2.80%)
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research

All right, everybody. We're going to get going with our next company presenter. Thank you for joining us at the BofA Annual Healthcare Conference. My name is Jason Gerber. I'm one of the biotech analysts, and I'm pleased to be introducing Axsome Therapeutics and Herriot Tabuteau, CEO. So first, Herriot, thanks so much for joining us.

Herriot Tabuteau
Axsome Therapeutics, Inc. - Founder, Chairman, CEO & President

Thanks, Jason, for having us. I think this is the first time that we're presenting at the BofA conference. So...

Questions & Answers

Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research

Maybe virtually in the past. But yes, it's good to have you in person. So a lot going on at the company. You've got some pipeline readouts, some regulatory advancements in the launch that's going on. And maybe just coming out of the quarter, any high-level thoughts or takeaways just in terms of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot